James Patrick Kelly, EVP, CFO and Treasurer of Novavax, is set to execute a planned stock transaction on 12/31/2024. Kelly will exercise options to acquire 35,000 shares of common stock at no cost, then immediately sell 16,906 shares at $8.04 per share to cover tax liabilities.The total value of the disposed shares amounts to $135,924.24. Following these transactions, Kelly's direct ownership in Novavax will increase to 32,602 shares. This pre-arranged transaction aligns with the company's executive compensation structure and tax obligation management practices.Investors should note that this future transaction is part of a planned executive stock option exercise and does not necessarily reflect the CFO's view on the company's current valuation or future prospects.

James Patrick Kelly, EVP, CFO and Treasurer of Novavax, is set to execute a planned stock transaction on 12/31/2024. Kelly will exercise options to acquire 35,000 shares of common stock at no cost, then immediately sell 16,906 shares at $8.04 per share to cover tax liabilities.The total value of the disposed shares amounts to $135,924.24. Following these transactions, Kelly's direct ownership in Novavax will increase to 32,602 shares. This pre-arranged transaction aligns with the company's executive compensation structure and tax obligation management practices.Investors should note that this future transaction is part of a planned executive stock option exercise and does not necessarily reflect the CFO's view on the company's current valuation or future prospects.